| Title: |
Co-design of patient information leaflets for germline predisposition to cancer: recommendations for clinical practice from the UK Cancer Genetics Group (UKCGG), Cancer Research UK (CRUK) funded CanGene-CanVar Programme and the Association of Genetic Nurse Counsellors (AGNC) |
| Authors: |
Kohut, Kelly; Speight, Beverley; Young, Julie; Way, Rosalind; Wiggins, Jennifer; Monje-Garcia, Laura; Eccles, Diana M; Foster, Claire; Turner, Lesley; Snape, Katie; Hanson, Helen; on behalf of the CanGene-CanVar Patient Reference Panel; on behalf of the Consensus Meeting Participants; Dale, Caroline; Duncombe, Sue; Gold, Rochelle; Patton, Sonia; Rook, Warren; Stevens, Richard; Vale, Frankie; White, Helen; Woodward, Ivan; Worrall, Steve; Barnett, Lily; Bartlett, Marion; Barwell, Julian; Bell, Dany; Bhinder, Bhavana; Bradford, Matilda; Brain, Lydia; Campbell, Victoria; Clark, Andrew; Clarke, Emily; Corbett, Gemma; Chauhan, Dharmisha; Cleaver, Ruth; Coad, Beth; Coulson, Alice; Cowley, Lorraine; Crosskey, Howard; Cuthill, Vicky; Dave, Ajay; Davidson, Rosemarie; Dugmore, Chris; Dunlop, Jacqueline; Eccles, Diana; Elliot, Courtney; Engelbrecht, Clair; Fernando, Malee; Freeman, Alexandra; Gibson, Sarah; Gomes, Joana; Gorrie, Jennifer; Green, Andrew; Halliday, Dorothy; Hiscock, Diane; Holliday, Deborah; Horton, Esther; Ingram, Wendy; James, Margaret; Jacobs-Pearson, Makaela; Jaggard, Charlotte; Jewell, Rosalyn; John, Siobhan; Johnes, Annie; Jones, Lynne; Kharay, Bhavana; Kulke, Claire; Large, Joanna; Lewis, Celine; Lowry, Anne; MacParland, Sianan; Mansell, Martin; Martin, Charlotte; Martin, Richard; McKeeve, Claire; McVeigh, Terri; Miles, Tracie; Monahan, Kevin; Murray, Alex; Musgrave, Hannah; Norman, Grace; Oborne, Emma; Ong, Kai Ren; Onyeador, Nicola; Ostrowski, Phil; Pitfield, Debbie; Raghavan, Manoj; Rea, Gillian; Reid, Alistair; Salter, Sarah; Scott, Gillian; Scrace, Collette; Searle, Claire; Shanmugasundaram, Monisha; Shepherd, Stan; Smith, Katherine; Snadden, Lelsey; Snowsill, Tristan; Springham, David; Stayner, Barbara; Tilbrook, Tilly; Torr, Bethany; Tsoulaki, Olga; Vicari, Stefania; Walsh, Hayley; Westbury, Sarah; Wilde, Lisa; Woodward, Emma |
| Publisher Information: |
BMJ Publishing Group Ltd |
| Publication Year: |
2024 |
| Collection: |
HighWire Press (Stanford University) |
| Subject Terms: |
Cancer genetics |
| Description: |
Background Testing for germline pathogenic variants (GPVs) in cancer predisposition genes is increasingly offered as part of routine care for patients with cancer. This is often urgent in oncology clinics due to potential implications on treatment and surgical decisions. This also allows identification of family members who should be offered predictive genetic testing. In the UK, it is common practice for healthcare professionals to provide a patient information leaflet (PIL) at point of care for diagnostic genetic testing in patients with cancer, after results disclosure when a GPV is identified, and for predictive testing of at-risk relatives. Services usually create their own PIL, resulting in duplication of effort and wide variability regarding format, content, signposting and patient input in co-design and evaluation. Methods Representatives from UK Cancer Genetics Group (UKCGG), Cancer Research UK (CRUK) funded CanGene-CanVar programme and Association of Genetic Nurse Counsellors (AGNC) held a 2-day meeting with the aim of making recommendations for clinical practice regarding co-design of PIL for germline cancer susceptibility genetic testing. Lynch syndrome and haematological malignancies were chosen as exemplar conditions. Results Meeting participants included patient representatives including as co-chair, multidisciplinary clinicians and other experts from across the UK. High-level consensus for UK recommendations for clinical practice was reached on several aspects of PIL using digital polling, including that PIL should be offered, accessible, co-designed and evaluated with patients. Conclusions Recommendations from the meeting are likely to be applicable for PIL co-design for a wide range of germline genetic testing scenarios. |
| Document Type: |
text |
| File Description: |
text/html |
| Language: |
English |
| Relation: |
http://jmg.bmj.com/cgi/content/short/61/2/142; http://dx.doi.org/10.1136/jmg-2023-109440 |
| DOI: |
10.1136/jmg-2023-109440 |
| Availability: |
http://jmg.bmj.com/cgi/content/short/61/2/142; https://doi.org/10.1136/jmg-2023-109440 |
| Rights: |
Copyright (C) 2024, BMJ Publishing Group Ltd |
| Accession Number: |
edsbas.E9CAC71 |
| Database: |
BASE |